Development of a core measurement set for research in degenerative cervical myelopathy: a study protocol (AO Spine RECODE-DCM CMS).
adult neurology
neurological injury
neurological pain
neurology
neuromuscular disease
neurosurgery
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
09 06 2022
09 06 2022
Historique:
entrez:
9
6
2022
pubmed:
10
6
2022
medline:
14
6
2022
Statut:
epublish
Résumé
Progress in degenerative cervical myelopathy (DCM) is hindered by inconsistent measurement and reporting. This impedes data aggregation and outcome comparison across studies. This limitation can be reversed by developing a core measurement set (CMS) for DCM research. Previously, the AO Spine Research Objectives and Common Data Elements for DCM (AO Spine RECODE-DCM) defined 'what' should be measured in DCM: the next step of this initiative is to determine 'how' to measure these features. This protocol outlines the steps necessary for the development of a CMS for DCM research and audit. The CMS will be developed in accordance with the guidance developed by the Core Outcome Measures in Effectiveness Trials and the Consensus-based Standards for the selection of health Measurement Instruments. The process involves five phases. In phase 1, the steering committee agreed on the constructs to be measured by sourcing consensus definitions from patients, professionals and the literature. In phases 2 and 3, systematic reviews were conducted to identify tools for each construct and aggregate their evidence. Constructs with and without tools were identified, and scoping reviews were conducted for constructs without tools. Evidence on measurement properties, as well as on timing of assessments, are currently being aggregated. These will be presented in phase 4: a consensus meeting where a multi-disciplinary panel of experts will select the instruments that will form the CMS. Following selection, guidance on the implementation of the CMS will be developed and disseminated (phase 5). A preliminary CMS review scheduled at 4 years from release. Ethical approval was obtained from the University of Cambridge (HBREC2019.14). Dissemination strategies will include peer-reviewed scientific publications; conference presentations; podcasts; the identification of AO Spine RECODE-DCM ambassadors; and engagement with relevant journals, funders and the DCM community.
Identifiants
pubmed: 35680260
pii: bmjopen-2021-060436
doi: 10.1136/bmjopen-2021-060436
pmc: PMC9185555
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e060436Subventions
Organisme : Medical Research Council
ID : MR/K025643/1
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
PLoS One. 2021 Sep 2;16(9):e0256997
pubmed: 34473796
Global Spine J. 2022 Feb;12(1_suppl):55S-63S
pubmed: 35174729
BMJ Open. 2019 May 5;9(5):e027000
pubmed: 31061045
BMC Med. 2018 Apr 30;16(1):63
pubmed: 29706132
Global Spine J. 2022 Feb;12(1_suppl):78S-96S
pubmed: 35174728
Trials. 2014 Jun 25;15:247
pubmed: 24962012
Nat Rev Neurol. 2020 Feb;16(2):108-124
pubmed: 31974455
Global Spine J. 2022 Feb;12(1_suppl):109S-121S
pubmed: 35174725
Patient. 2017 Apr;10(2):141-152
pubmed: 27704486
Trials. 2007 Nov 26;8:39
pubmed: 18039365
J Health Serv Res Policy. 2006 Jul;11(3):172-9
pubmed: 16824265
BMC Med Res Methodol. 2018 Jul 6;18(1):73
pubmed: 29976134
J Invest Dermatol. 2015 Jan;135(1):24-30
pubmed: 25186228
Global Spine J. 2022 Feb;12(1_suppl):159S-171S
pubmed: 35174727
J Health Serv Res Policy. 2006 Oct;11(4):218-24
pubmed: 17018195
Spine (Phila Pa 1976). 2021 Dec 15;46(24):E1353-E1358
pubmed: 33973559
Eur Spine J. 2015 Apr;24 Suppl 2:209-28
pubmed: 24005994
Global Spine J. 2022 Feb;12(1_suppl):28S-38S
pubmed: 35174734
PLoS Med. 2017 Nov 16;14(11):e1002447
pubmed: 29145404
Global Spine J. 2022 Feb;12(1_suppl):147S-158S
pubmed: 35174733
Acad Med. 2016 May;91(5):663-8
pubmed: 26796090
JMIR Form Res. 2021 Feb 3;5(2):e18732
pubmed: 33533719
Acta Neurochir (Wien). 2021 Jun;163(6):1561-1568
pubmed: 33625603
Global Spine J. 2022 Feb;12(1_suppl):97S-108S
pubmed: 35174735
Lancet. 2014 Jan 11;383(9912):156-65
pubmed: 24411644
J Clin Epidemiol. 2014 Jul;67(7):745-53
pubmed: 24582946
Spine (Phila Pa 1976). 2015 Jun 15;40(12):E675-93
pubmed: 25839387
Global Spine J. 2022 Feb;12(1_suppl):130S-146S
pubmed: 34797993
Global Spine J. 2022 Feb;12(1_suppl):122S-129S
pubmed: 35174730
World Neurosurg. 2017 Oct;106:699-706
pubmed: 28065875
Trials. 2016 Sep 13;17(1):449
pubmed: 27618914
Psychiatry Res. 2020 Jan;283:112376
pubmed: 31036287
Qual Life Res. 2009 Oct;18(8):1115-23
pubmed: 19711195
JMIR Res Protoc. 2020 Jun 11;9(6):e15922
pubmed: 32525490
Global Spine J. 2017 Sep;7(3 Suppl):70S-83S
pubmed: 29164035
BMJ Open. 2022 Jan 19;12(1):e057650
pubmed: 35046007
Global Spine J. 2022 Feb;12(1_suppl):64S-77S
pubmed: 34971524
BMJ Open. 2019 Oct 10;9(10):e031486
pubmed: 31601597
Spine (Phila Pa 1976). 2013 Oct 15;38(22 Suppl 1):S111-22
pubmed: 23963009
PLoS Med. 2016 Oct 18;13(10):e1002148
pubmed: 27755541
Lancet Neurol. 2021 Feb;20(2):98-106
pubmed: 33357512
BMJ. 2018 Feb 22;360:k186
pubmed: 29472200
J R Soc Med. 2011 Dec;104(12):510-20
pubmed: 22179294
Global Spine J. 2022 Feb;12(1_suppl):5S-7S
pubmed: 35174732
Trials. 2013 Jan 22;14:21
pubmed: 23339751
Lancet. 2014 Jan 11;383(9912):166-75
pubmed: 24411645
JBI Database System Rev Implement Rep. 2019 Mar;17(3):261-266
pubmed: 30451709
Implement Sci. 2017 Feb 28;12(1):28
pubmed: 28245849
Global Spine J. 2022 Feb;12(1_suppl):39S-54S
pubmed: 35174726
Global Spine J. 2022 Feb;12(1_suppl):19S-27S
pubmed: 35174731
Trials. 2017 Jun 20;18(Suppl 3):280
pubmed: 28681707
Global Spine J. 2020 Jun;10(4):476-485
pubmed: 32435569
PLoS One. 2017 Mar 1;12(3):e0172564
pubmed: 28249017
Health Info Libr J. 2021 Aug 19;:
pubmed: 34409722
Global Spine J. 2019 May;9(1 Suppl):65S-76S
pubmed: 31157148
Global Spine J. 2022 Feb;12(1_suppl):8S-18S
pubmed: 34879754
Global Spine J. 2022 Apr;12(3):432-440
pubmed: 33203262
BMJ Open. 2020 Jan 20;10(1):e035505
pubmed: 31964677
BMJ. 2010 Feb 15;340:c365
pubmed: 20156912
J Bone Joint Surg Am. 2013 Sep 18;95(18):1651-8
pubmed: 24048552
Qual Life Res. 2018 May;27(5):1159-1170
pubmed: 29550964
Spine (Phila Pa 1976). 2015 Sep 1;40(17):1322-8
pubmed: 26020847
BMJ. 2017 May 17;357:j2262
pubmed: 28515234
Syst Rev. 2016 Aug 02;5(1):129
pubmed: 27484996
Qual Life Res. 2018 May;27(5):1171-1179
pubmed: 29260445
Int J Clin Pharm. 2016 Jun;38(3):655-62
pubmed: 26846316
J Speech Lang Hear Res. 2017 Jan 1;60(1):62-88
pubmed: 28030869
Qual Life Res. 2018 May;27(5):1147-1157
pubmed: 29435801
BMJ. 2020 Jan 16;368:l6890
pubmed: 31948937
PLoS One. 2016 Aug 02;11(8):e0157263
pubmed: 27482710
J Clin Neurosci. 2021 Aug;90:76-81
pubmed: 34275584